CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$117,900
-100%
Shares
Shares Volume: 5,000 Shares
Average Share Price: $23.58
INSIDER
Quinlan Paul T
General Counsel (Officer)
reported on Jan 16 2024
traded on Jan 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 0 |
| PURCHASES/SALES 1Y | 0 / 8 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $178,688.75 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 29 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $304,975.1 |
| COMPANY PREVIOUS TRADES |